Moderna's coronavirus vaccine faces U.S. FDA expert panel review

Mitchell Daily Republic

Dec 17, 2020

The FDA advisory committee is likely to discuss Moderna's reports of side effects from its 30,000-person trial, which were more frequent than those reported by Pfizer.